1. Home
  2. CMPX vs OBA Comparison

CMPX vs OBA Comparison

Compare CMPX & OBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • OBA
  • Stock Information
  • Founded
  • CMPX 2014
  • OBA 2024
  • Country
  • CMPX United States
  • OBA Canada
  • Employees
  • CMPX N/A
  • OBA N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • OBA
  • Sector
  • CMPX Health Care
  • OBA
  • Exchange
  • CMPX Nasdaq
  • OBA Nasdaq
  • Market Cap
  • CMPX 291.8M
  • OBA 314.7M
  • IPO Year
  • CMPX N/A
  • OBA 2025
  • Fundamental
  • Price
  • CMPX $3.51
  • OBA $9.93
  • Analyst Decision
  • CMPX Strong Buy
  • OBA
  • Analyst Count
  • CMPX 8
  • OBA 0
  • Target Price
  • CMPX $13.50
  • OBA N/A
  • AVG Volume (30 Days)
  • CMPX 876.2K
  • OBA 103.2K
  • Earning Date
  • CMPX 11-11-2025
  • OBA 01-01-0001
  • Dividend Yield
  • CMPX N/A
  • OBA N/A
  • EPS Growth
  • CMPX N/A
  • OBA N/A
  • EPS
  • CMPX N/A
  • OBA N/A
  • Revenue
  • CMPX N/A
  • OBA N/A
  • Revenue This Year
  • CMPX N/A
  • OBA N/A
  • Revenue Next Year
  • CMPX N/A
  • OBA N/A
  • P/E Ratio
  • CMPX N/A
  • OBA N/A
  • Revenue Growth
  • CMPX N/A
  • OBA N/A
  • 52 Week Low
  • CMPX $1.27
  • OBA $9.93
  • 52 Week High
  • CMPX $4.08
  • OBA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 59.49
  • OBA N/A
  • Support Level
  • CMPX $3.37
  • OBA N/A
  • Resistance Level
  • CMPX $3.77
  • OBA N/A
  • Average True Range (ATR)
  • CMPX 0.19
  • OBA 0.00
  • MACD
  • CMPX 0.01
  • OBA 0.00
  • Stochastic Oscillator
  • CMPX 46.87
  • OBA 0.00

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About OBA Oxley Bridge Acquisition Limited Class A Ordinary Shares

Oxley Bridge Acquisition Ltd is a blank check company.

Share on Social Networks: